Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya J, Dueñas C, Irazola I, de Los Santos I, de la Fuente S, Gil D, Hernández C, Galindo MJ, Gómez J, Delgado E, Moreno-García E, Pousada G, Aldámiz T, Iribarren JA, Guerra JM, Morán MÁ, Galera C, De La Fuente J, Peláez A, Cervero M, Garcinuño M, Montero M, Ceballos F, Buzón L; on behalf of the DORIPEX Study Group. Troya J, et al. Among authors: duenas c. Medicine (Baltimore). 2022 Jun 17;101(24):e29252. doi: 10.1097/MD.0000000000029252. Medicine (Baltimore). 2022. PMID: 35713430 Free PMC article.
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.
Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, Carratalà J, Pachón J, Carcas AJ, Yllescas M, Arribas JR; COVID-19@Spain and COVID@HULP Study Groups. Berenguer J, et al. Thorax. 2021 Sep;76(9):920-929. doi: 10.1136/thoraxjnl-2020-216001. Epub 2021 Feb 25. Thorax. 2021. PMID: 33632764 Free PMC article.
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
Buzón L, Dueñas C, Pedrero R, Iribarren JA, de Los Santos I, Díaz de Santiago A, Morán MÁ, Pousada G, Moreno E, Ferreira E, Iglesias A, Martín C, Gómez J, Rodríguez L, Egido M, Sepulveda MA, Troya J. Buzón L, et al. Among authors: duenas c. Viruses. 2023 Jan 24;15(2):322. doi: 10.3390/v15020322. Viruses. 2023. PMID: 36851536 Free PMC article. Clinical Trial.
A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model.
Vizcarra P, Moreno A, Vivancos MJ, Muriel García A, Ramirez Schacke M, González-Garcia J, Curran A, Palacios R, Sánchez Guirao AJ, Reus Bañuls S, Moreno Guillén S, Casado JL; Spanish HIV Research Network (CoRIS). Vizcarra P, et al. J Bone Miner Res. 2023 Oct;38(10):1443-1452. doi: 10.1002/jbmr.4894. Epub 2023 Aug 23. J Bone Miner Res. 2023. PMID: 37545089 Free article.
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.
Álvarez-Ossorio MJ, Sarmento E Castro R, Granados R, Macías J, Morano-Amado LE, Ríos MJ, Merino D, Álvarez EN, Collado A, Pérez-Pérez M, Téllez F, Martín JM, Méndez J, Pineda JA, Neukam K; HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups. Álvarez-Ossorio MJ, et al. J Viral Hepat. 2018 Jun;25(6):699-706. doi: 10.1111/jvh.12867. Epub 2018 Feb 27. J Viral Hepat. 2018. PMID: 29377515
Redefining therapeutic success in HIV patients: an expert view.
Antela A, Rivero A, Llibre JM, Moreno S; RET Group. Antela A, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2501-2518. doi: 10.1093/jac/dkab168. J Antimicrob Chemother. 2021. PMID: 34077524 Free PMC article. Review.
137 results